GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (FRA:2XJ0) » Definitions » Forward PE Ratio

Avalon Globocare (FRA:2XJ0) Forward PE Ratio : 0.00 (As of Jun. 19, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Avalon Globocare Forward PE Ratio?

Avalon Globocare's Forward PE Ratio for today is 0.00.

Avalon Globocare's PE Ratio without NRI for today is 0.00.

Avalon Globocare's PE Ratio for today is 0.00.


Avalon Globocare Forward PE Ratio Historical Data

The historical data trend for Avalon Globocare's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare Forward PE Ratio Chart

Avalon Globocare Annual Data
Trend
Forward PE Ratio

Avalon Globocare Quarterly Data
Forward PE Ratio

Competitive Comparison of Avalon Globocare's Forward PE Ratio

For the Real Estate Services subindustry, Avalon Globocare's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalon Globocare's Forward PE Ratio Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Avalon Globocare's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Avalon Globocare's Forward PE Ratio falls into.



Avalon Globocare Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Avalon Globocare  (FRA:2XJ0) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Avalon Globocare Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalon Globocare (FRA:2XJ0) Business Description

Traded in Other Exchanges
Address
4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Avalon Globocare (FRA:2XJ0) Headlines

No Headlines